Evidence map›Paper›PMID 35685829›Full record

ArticleClinical case reports2022

Orbital inflammatory disease following mRNA SARS-CoV-2 vaccine.

Solange Grunenwald, Gabriel Lethellier, Philippe Imbert, Céline Dekeister, Philippe Caron

Open access · goldAbstract read
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Solange GrunenwaldMultidisciplinary Thyroid-Eye Outpatient Clinic Department of Endocrinology and Metabolic Disease Cardio-Vascular and Metabolic Unit CHU Larrey (University Hospital Centre) Toulouse France.
Gabriel LethellierDepartment of Ophthalmology CH intercommunal Castres-Mazamet Castres France.
Philippe ImbertMultidisciplinary Thyroid-Eye Outpatient Clinic Department of Endocrinology and Metabolic Disease Cardio-Vascular and Metabolic Unit CHU Larrey (University Hospital Centre) Toulouse France.
Céline DekeisterMultidisciplinary Thyroid-Eye Outpatient Clinic Department of Endocrinology and Metabolic Disease Cardio-Vascular and Metabolic Unit CHU Larrey (University Hospital Centre) Toulouse France.
Philippe CaronMultidisciplinary Thyroid-Eye Outpatient Clinic Department of Endocrinology and Metabolic Disease Cardio-Vascular and Metabolic Unit CHU Larrey (University Hospital Centre) Toulouse France.ORCID https://orcid.org/0000-0001-5391-7582
Centre Hospitalier Intercommunal Castres-Mazamet · FRHôpital Paule de Viguier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 65-year-old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine. The temporal relationship between the COVID-19 vaccination and orbital symptoms suggests a probable link between SARS-CoV-2 mRNA vaccine and this orbital inflammatory disease.

Indexed as

ASIACOVID‐19orbital inflammatory diseaseorbitopathySARS‐CoV‐2side effectsvaccines

Identifiers

PMID35685829
PMCPMC9172587
OpenAlexW4281725694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.